bsd13g083108.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Schedule 13G
 
Under the Securities Exchange Act of 1934
 
(Amendment No. _____)
 

 
BSD Medical Corporation
(Name of Issuer)
 

 
Common Stock, par value $0.001 per share
(Title of Class of Securities)
 

 
055662100
(CUSIP Number)
 

 
August 31, 2008
(Date of Event Which Requires Filing of this Statement)
 

 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
o Rule 13d-1(b)
o Rule 13d-1(c)
x Rule 13d-1(d)


 
 

 
Page 2 of 8

CUSIP NO.  055662100
 
1.
Name of reporting persons:  Paul F. Turner
 
 
2.
Check the appropriate box if a member of a group:
 
(a)   o
(b)   o

3.         SEC use only:
 
4.         Citizenship or place of organization:
 
United States
 
Number of shares beneficially owned by each reporting person with:
 
5.
Sole voting power:
 
 
384,836 (1)
 
6.
Shared voting power:
 
 
1,710,158
 
7.
Sole dispositive power:
 
 
384,836 (1)
 
8.
Shared dispositive power:
 
 
1,710,158 (2)
 
9.
Aggregate amount beneficially owned by each reporting person:
 
 
2,094,994 (1)(2)
 
10.
Check if the aggregate amount in Row (9) excludes certain shares
 
 
11.
Percent of class represented by amount in Row 9:
 
 
9.8%
 
12.
Type of reporting person:
 
 
IN
 
 
(1)   Includes 277,212 stock options to purchase common stock that were exercisable at August 31, 2008 or within 60 days of August 31, 2008.
 
 
(2)   Represents 1,710,158 shares held by Family Focus TH Limited (“Family Focus”).  Paul Turner and Judith Turner share voting power and investment power over Family Focus.
 
 
 
 

Page 3 of 8
 
CUSIP NO.  055662100
 
1.
Name of reporting persons:  Judith Turner
 
 
2.
Check the appropriate box if a member of a group:
 
(a)   o
(b)   o

3.         SEC use only:
 
4.         Citizenship or place of organization:
 
United States
 
Number of shares beneficially owned by each reporting person with:
 
5.
Sole voting power:
 
 
0
 
6.
Shared voting power:
 
 
1,710,158 (1)
 
7.
Sole dispositive power:
 
 
0
 
8.
Shared dispositive power:
 
 
1,710,158 (1)
 
9.
Aggregate amount beneficially owned by each reporting person:
 
 
1,710,158 (1)
 
10.
Check if the aggregate amount in Row (9) excludes certain shares
 
11.
Percent of class represented by amount in Row 9:
 
 
8.0%
 
12.
Type of reporting person:
 
 
IN
 
 
(1)  Represents 1,710,158 shares held by Family Focus.  Paul Turner and Judith Turner share voting power and investment power over Family Focus.
 
 
 
 

Page 4 of 8
 
CUSIP NO.  055662100
 
1.
Name of reporting persons:   Family Focus TH Limited
 
 
2.
Check the appropriate box if a member of a group:
 
(a)   o
(b)   o

3.         SEC use only:
 
4.         Citizenship or place of organization:
 
Utah
 
Number of shares beneficially owned by each reporting person with:
 
5.
Sole voting power:
 
 
0
 
6.
Shared voting power:
 
 
1,710,158 (1)
 
7.
Sole dispositive power:
 
 
0
 
8.
Shared dispositive power:
 
 
1,710,158 (1)
 
9.
Aggregate amount beneficially owned by each reporting person:
 
 
1,710,158 (1)
 
10.
Check if the aggregate amount in Row (9) excludes certain shares
 
11.
Percent of class represented by amount in Row 9:
 
 
8.0%
 
12.
Type of reporting person:
 
 
PN
 
(1)  Represents 1,710,158 shares held by Family Focus.  Paul Turner and Judith Turner share voting power and investment power of Family Focus.
 
 
 
 

Page 5 of 8
 
Item 1(a).  Name of issuer:
BSD Medical Corporation
 
Item 1(b).  Address of issuer’s principal executive offices:
2188 West 2200 South
Salt Lake City, Utah 84119
 
Item 2(a).  Names of person filing:
Paul Turner
Judith Turner
Family Focus
 
Item 2(b).  Address of principal business office or, if none, Residence:
c/o BSD Medical Corporation
2188 West 2200 South
Salt Lake City, Utah 84119
 
Item 2(c). Citizenship:
Paul Turner, United States
Judith Turner, United States
Family Focus, Utah
 
Item 2(d). Title of class of securities:
Common Stock, par value $0.001 per share
 
Item 2(e).  CUSIP No.:
055662100
 
Item 3.
If this statement is filed pursuant to Secs. 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
Not Applicable
 
Item 4.
Ownership
Reference is made to Rows 5-9 and 11 of each of the cover pages of this Schedule 13G and associated footnotes, which Rows and footnotes are incorporated by reference herein.

Item 5.
Ownership of Five percent or Less of a Class:
 
Not Applicable
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person:
 
Not Applicable
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
 
Not Applicable
 
 
 
 

Page 6 of 8
 
Item 8.
Identification and Classification of Members of the Group:
 
See Item 4 of this Schedule 13G and the Joint Filing Agreement attached hereto as Exhibit 1.
 
Item 9.
Notice of Dissolution of Group:
 
Not Applicable
 
Item 10.
Certifications:
 
Not Applicable
 

 
 

 
Page 7 of 8
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated:  October 15, 2008
 
 
/s/ Paul Turner
 
Paul Turner
   
 
/s/ Judith Turner
 
Judith Turner
   
     
 
FAMILY FOCUS
     
     
 
By:
/s/ Paul Turner
   
Paul Turner, Manager
     
 
By:
/s/ Judith Turner
   
Judith Turner, Manager
 
 

 
 

 

Exhibit 1
 
JOINT FILING AGREEMENT
 
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Schedule 13G (including amendments thereto) with respect to the common stock of BSD Medical Corporation and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.
 
Dated:  October 15, 2008
 
 
/s/ Paul Turner
 
Paul Turner
   
 
/s/ Judith Turner
 
Judith Turner
   
     
 
FAMILY FOCUS
     
     
 
By:
/s/ Paul Turner
   
Paul Turner, Manager
     
 
By:
/s/ Judith Turner
   
Judith Turner, Manager